Duration of anticoagulation and risk of recurrent thromboembolism in carriers of factor V Leiden or prothrombin mutation

J Thromb Haemost. 2008 Dec;6(12):2223-4. doi: 10.1111/j.1538-7836.2008.03173.x. Epub 2008 Oct 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anticoagulants / therapeutic use*
  • Factor V / genetics*
  • Follow-Up Studies
  • Heterozygote
  • Humans
  • Middle Aged
  • Prothrombin / genetics*
  • Secondary Prevention
  • Thromboembolism / drug therapy*
  • Thromboembolism / pathology
  • Young Adult

Substances

  • Anticoagulants
  • factor V Leiden
  • Factor V
  • Prothrombin